Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ODI Pharma ABXSAT:ODI -11.02%46 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates XSAT:ODI with a GF Score™ of 46/100 and a GF Value™ of kr9.53 (Significantly Undervalued). Among 923 Drug Manufacturers companies, ODI Pharma AB ranks worse than 108342.25% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). ODI Pharma AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr0.00 Mil. ODI Pharma AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr9.27 Mil.
Hence, ODI Pharma AB's Days Inventory for the
three
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for ODI Pharma AB's Days Inventory or its related term are showing as below:
During the past 7 years, ODI Pharma AB's highest Days Inventory was 782.52. The lowest was 16.70. And the median was 502.35.
XSAT:ODI's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.38 * Ranked among companies with meaningful Days Inventory only.
ODI Pharma AB's Days Inventory
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ODI Pharma AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.00.
ODI Pharma AB (XSAT:ODI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ODI Pharma AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ODI Pharma AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ODI Pharma AB Days Inventory Related Terms
ODI Pharma AB Days Inventory Historical Data
* Premium members only.
The historical data trend for ODI Pharma AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ODI vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ODI Pharma AB Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where ODI Pharma AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ODI Pharma AB (XSAT:ODI) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ODI Pharma AB and its competitors. Over the past decade, ODI Pharma AB's Days Inventory has ranged from 16.70 to 782.52. According to the industry distribution chart, ODI Pharma AB ranks #999999 out of 923 companies in the Drug Manufacturers industry.
Is ODI Pharma AB's Days Inventory too high?
ODI Pharma AB's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 16.70 to a high of 782.52. Based on the distribution chart, ODI Pharma AB ranks #999999 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ODI Pharma AB has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ODI Pharma AB ranks #999999 out of 923 companies for Days Inventory. This places ODI Pharma AB in the lower half of its industry. The industry median Days Inventory is 164.38. Historically, ODI Pharma AB's own Days Inventory has ranged from 16.70 to 782.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ODI Pharma AB and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ODI Pharma AB's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, ODI Pharma AB (XSAT:ODI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr9.53, compared to a current price of kr2.26 — trading 76.3% below its estimated fair value. The current Days Inventory is 0.00. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ODI Pharma AB (XSAT:ODI), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?
Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued.
The current stock price of kr2.26 is trading 76.3% below its estimated GF Value™ of kr9.53.
GuruFocus considers ODI Pharma AB to be Significantly Undervalued.
Key valuation signals for XSAT:ODI:
Days Inventory: 0.00
GF Value™: kr9.53 vs. price of kr2.26 (76.3% below fair value)
No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ODI has been successfully added to your 
